Astera Labs expects Q3 revenue of $540M-$560M as Scorpio becomes largest product line (NASDAQ:ALAB)
Astera Labs (ALAB) Q2 2026 earnings call: record $392M revenue, PCIe 6 >50% mix, Scorpio X ramps.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Astera Labs (ALAB) Q2 2026 earnings call: record $392M revenue, PCIe 6 >50% mix, Scorpio X ramps.
Astera Labs expects Q3 revenue of $540M-$560M as Scorpio becomes largest product line (NASDAQ:ALAB) | Seeking Alpha
Earnings Call Insights: Astera Labs (ALAB) Q2 2026
Management View
Jitendra Mohan (Co-Founder, CEO & Executive Director) said the company delivered ârecord revenue of $392.4 millionâ and tied the quarterâs strength to âbroad-based strength across our entire product portfolio,â adding that PCIe 6 ârepresenting more than 50% of our total revenue driven
Seeking Alpha's Disclaimer:
This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Quick Insights
What is driving Astera Labs' revenue and product mix shift in the latest quarter?
Broad-based strength across the product portfolio, especially Scorpio X-Series and Aries PCIe 6 Retimers, with PCIe 6 representing over 50% of revenue versus 1/3 in the prior quarter.
How soon will Scorpio become Astera Labs' largest product line by revenue?
Scorpio is expected to become the largest product line by revenue in Q3, one quarter earlier than previously expected.
What guidance and margin trajectory has Astera Labs provided for the next quarter?
Management guided Q3 revenue to $540-$560 million, non-GAAP operating margin around 43%, gross margin about 72%, and EPS of $1.16 to $1.21; long-term gross margin target is 78%.
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Twist Bioscience prices upsized $300M equity at $96 per share (TWST:NASDAQ)
Twist Bioscience (TWST) priced an upsized underwritten public offering of 3.125M common shares at $96.00 per share.
Finance of America reaffirms 2026 adjusted EPS of $4.50-$5.00 as Onity $5.2B HECM MSR deal closes (NYSE:FOA)
Finance of America (FOA) Q2 2026 earnings call: reverse mortgage growth, Onity MSR deal, GAAP volatility, and reaffirmed guidanceâread now.
Mitsubishi Electric launches S-EIV-X to boost regenerative braking power use (MIELY:OTCMKTS)
Mitsubishi Electric launches S-EIV-X inverter subscription to cut rail station energy costs using surplus regenerative braking power plus remote...
B&G Foods Declares $0.095 Per Share Dividend, Reinforcing Shareholder Return Commitment
B&G Foods announced a quarterly dividend of $0.095 per share, payable on April 1, 2025. This article covers dividend details, industry context, and investor perspectives, analyzing the company's outlook and capital allocation strategy.
